EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Systemic Corticosteroid-Related Adverse Outcomes Among Patients With Chronic Rhinosinusitis With Nasal Polyps

Laura Valle Soto, Amee Manges, Anne Gadermann, Andrew Thamboo, Jason M Sutherland iD

Journal of Otolaryngology - Head & Neck Surgery · 2026-11 · 55

DOI: 10.1177/19160216261505375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Otolaryngology - Head & Neck Surgery, online erschienen am 20.11.2026. Verfasst von Laura Valle Soto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Health Services and Policy Research, University of British Columbia, Vancouver, BC, Canada. Hauptthemen laut MEDLINE: Rhinosinusitis, Nasal Polyps, Adrenal Cortex Hormones, Sinusitis. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance: Systemic corticosteroids (SCS) are widely prescribed in chronic rhinosinusitis with nasal polyps (CRSwNP), yet no strict guidelines standardize their use. Growing evidence in respiratory disease supports a dose-response relationship between SCS use and adverse health outcomes, with risk increasing at relatively low cumulative doses.

Objective

Measure associations between SCS use and adverse health outcomes.

Design

A population-based retrospective cohort study was conducted using community-based pharmacy claims data.

Setting

British Columbia, Canada, between January 1, 2010 and December 31, 2022.

Participants

Eligible cohort members were adult insured residents diagnosed with CRSwNP who had at least 2 years of dispensing data. Exposure or Intervention: SCS exposure. Main Outcome Measures: Incidence of adverse clinical outcomes.

Results

A total of 6219 patients with CRSwNP were included. The hazard of experiencing any adverse outcome was 17% higher among SCS-exposed patients compared with the unexposed group (adjusted hazard ratio 1.17; 95% CI, 1.06-1.29). Most individual outcomes—including bone-related conditions, infections, cardio/cerebrovascular disease, cataract, glaucoma, hypertension, and type 2 diabetes showed significantly increased hazards among patients in the 0.5 to 0 to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RhinosinusitisNasal PolypsAdrenal Cortex HormonesSinusitisRhinitisHumansFemaleMaleChronic DiseaseRetrospective StudiesMiddle AgedAdultBritish ColumbiaDose-Response Relationship, DrugAgedIncidence

Stichwörter der Autor:innen

adverse effectsglucocorticoidsnasal polypsrhinosinusitis

Substanzen

Adrenal Cortex Hormones

Autor:innen und Institutionen

  • Centre for Health Services and Policy Research, University of British Columbia, Vancouver, BC, Canada.
  • School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
  • Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of British Columbia, Vancouver, BC, Canada.

ORCID-Profile: Jason M Sutherland

Zitieren

APA

Valle Soto, L., Manges, A., Gadermann, A., Thamboo, A., & Sutherland, J. M. (2026). Systemic Corticosteroid-Related Adverse Outcomes Among Patients With Chronic Rhinosinusitis With Nasal Polyps. Journal of Otolaryngology - Head & Neck Surgery, 55. https://doi.org/10.1177/19160216261505375

Vancouver

Valle Soto L, Manges A, Gadermann A, Thamboo A, Sutherland JM. Systemic Corticosteroid-Related Adverse Outcomes Among Patients With Chronic Rhinosinusitis With Nasal Polyps. Journal of Otolaryngology - Head & Neck Surgery. 2026;55. doi:10.1177/19160216261505375

BibTeX
@article{ValleSoto2026,
  author = {Valle Soto, Laura and Manges, Amee and Gadermann, Anne and Thamboo, Andrew and Sutherland, Jason M},
  title = {Systemic Corticosteroid-Related Adverse Outcomes Among Patients With Chronic Rhinosinusitis With Nasal Polyps},
  journal = {Journal of Otolaryngology - Head & Neck Surgery},
  year = {2026},
  volume = {55},
  doi = {10.1177/19160216261505375}
}
Kostenlos starten →